Core Viewpoint - Yidu Technology (02158) has seen a stock price increase of over 5%, currently trading at 6.65 HKD, with a transaction volume of 69.47 million HKD, following the announcement of its collaboration with Guangdong Medical University Affiliated Hospital on a specialized database for vascular diseases and the "Meiyi Intelligent Body" [1] Group 1: Product Development and Innovation - The "Meiyi Intelligent Body," developed in collaboration with Guangdong Medical University, represents Yidu Technology's first application of its large model in the medical aesthetics field [1] - The company showcased its technological advancements at the 2025 Academic Annual Meeting of the Guangdong Provincial Hospital Association's Plastic Surgery Professional Committee [1] Group 2: Digital Health Initiatives - At the 2025 Digital Therapy Conference, Yidu Technology reported its involvement in the "2+3" diabetes management project in Hainan, highlighting its achievements since the pilot program began in 2023 [1] - The collaboration with Ling Shui County has resulted in 99.09% of managed patients being integrated into a systematic care program, with significant improvements in fasting blood glucose and glycated hemoglobin levels, increasing by 18.63% and 4.68% respectively, surpassing the provincial average [1] - The company plans to expand its AI healthcare innovations to other cities such as Sanya, Wanning, Qionghai, and Wenchang, and aims to extend digital therapy services to more chronic diseases like hypertension, targeting coverage for over 100,000 regional patients by 2025 [1]
医渡科技午后涨超5% 携手广附院推出美易智能体 大模型首次应用于医美领域